NFTY - First Trust India NIFTY 50 Equal Weight ETF
Assets | $68.44M |
NAV | $40.26 |
Expense Ratio | 0.80% |
PE Ratio | 17.83 |
Beta (5Y) | 0.84 |
Dividend (ttm) | $0.28 |
Dividend Yield | 0.68% |
Ex-Dividend Date | Mar 25, 2021 |
1-Year Return | - |
Trading Day | April 21 |
Last Price | $40.04 |
Previous Close | $40.50 |
Change ($) | -0.46 |
Change (%) | -1.14% |
Day's Open | 40.11 |
Day's Range | 39.92 - 40.38 |
Day's Volume | 72,166 |
52-Week Range | 23.44 - 44.00 |
Fund Description
The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NIFTY 50 Equal Weight Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks that comprise the index. The index is designed to track the performance of the 50 largest and most liquid Indian securities listed on the National Stock Exchange of India (NSE) by investing in all of the components of the NIFTY 50.
Asset Class Equity | Inception Date Feb 14, 2012 |
Exchange NASDAQ | Ticker Symbol NFTY |
Index Tracked NIFTY 50 Equal Weight Index |
Top 10 Holdings
23.06% of assetsName | Symbol | Weight |
---|---|---|
JSW Steel Limited | JSWSTEEL.NS | 2.77% |
Tata Steel Limited | TATASTEEL.NS | 2.42% |
Cipla Limited | n/a | 2.37% |
Wipro Limited | WIPRO.NS | 2.33% |
Hindalco Industries Limited | HINDALCO.NS | 2.27% |
Dr. Reddy''s Laboratories Limited | DRREDDY.NS | 2.24% |
Sun Pharmaceutical Industries Limited | SUNPHARMA.NS | 2.19% |
Divi''s Laboratories Limited | DIVISLAB.NS | 2.17% |
Hindustan Unilever Limited | HINDUNILVR.NS | 2.15% |
Shree Cement Limited | SHREECEM.NS | 2.15% |
Dividends
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 25, 2021 | $0.1364 | Mar 31, 2021 |
Dec 24, 2020 | $0.013 | Dec 31, 2020 |
Jun 25, 2020 | $0.126 | Jun 30, 2020 |
Mar 26, 2020 | $0.0928 | Mar 31, 2020 |
Sep 25, 2019 | $0.1868 | Sep 30, 2019 |
Jun 14, 2019 | $0.0479 | Jun 28, 2019 |
Favorable demographics, rising middle-income population, vaccine rollout and easy money policy have been driving economic growth of India. Stocks have been surging and foreign investors have been pourin...
India stocks and ETFs should fare better in the near term on the announcement of a mammoth stimulus.
India???s growth forecasts have been cut by global agencies to reflect the COVID-19 impact. But a still-highest growth rate in the G-20 bloc and oil savings should boost India ETFs.